Pontone, Gregory M.

Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease

Pontone, G. M., Williams, J. R., Anderson, K. E., Chase, G., Goldstein, S. A., Grill, S., Hirsch, E. S., Lehmann, S., Little, J. T., Margolis, R. L., et al. (2009) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 305

The Parkinson Anxiety Scale (PAS): Development and validation of a new anxiety scale

Leentjens, A. F. G., Dujardin, K., Pontone, G. M., Starkstein, S. E., Weintraub, D., & Martinez‐Martin, P. (2014) · Movement Disorders

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychometric Methodologies and Testing

Cited by 270

Optimal Treatment of Depression and Anxiety in Parkinson's Disease

Pontone, G. M., & Mills, K. A. (2021) · The American Journal of Geriatric Psychiatry

Parkinson's Disease Mechanisms and TreatmentsTreatment of Major Depression

Cited by 67

Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta‐analysis

Mills, K. A., Greene, M. C., Dezube, R., Goodson, C., Karmarkar, T., & Pontone, G. M. (2018) · International Journal of Geriatric Psychiatry

Parkinson's Disease Mechanisms and TreatmentsTreatment of Major Depression

Cited by 63

Neuropsychiatric Disorders and Potentially Preventable Hospitalizations in a Prospective Cohort Study of Older Americans

Davydow, D. S., Zivin, K., Katon, W. J., Pontone, G. M., Chwastiak, L., Langa, K. M., & Iwashyna, T. J. (2014) · Journal of General Internal Medicine

Dementia and Cognitive Impairment ResearchChronic Disease Management Strategies

Cited by 57

Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease

Hinkle, J. T., Perepezko, K., Mills, K. A., Mari, Z., Butala, A., Dawson, T. M., Pantelyat, A., Rosenthal, L. S., & Pontone, G. M. (2018) · Parkinsonism & Related Disorders

Parkinson's Disease Mechanisms and TreatmentsGastrointestinal motility and disorders

Cited by 49

Staying hidden: The burden of stigma in PD

McDaniels, B., Pontone, G. M., Mathur, S., & Subramanian, I. (2023) · Parkinsonism & Related Disorders

Parkinson's Disease Mechanisms and TreatmentsMental Health Treatment and Access

Cited by 44

“Pseudo-syndromes” associated with Parkinson disease, dementia, apathy, anxiety, and depression

Weiss, H. D., & Pontone, G. M. (2019) · Neurology Clinical Practice

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 21

Towards cascading genetic risk in Alzheimer’s disease

Altmann, A., Aksman, L. M., Oxtoby, N. P., Young, A. L., ADNI, Weiner, M., Aisen, P., Petersen, R., Weiner, M., Aisen, P., et al. (2024) · Brain

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 18

Deep learning to quantify the pace of brain aging in relation to neurocognitive changes

Yin, C., Imms, P., Chowdhury, N. F., Chaudhari, N. N., Ping, H., Wang, H., Bogdan, P., Irimia, A., Initiative, T. A. D. N., Weiner, M., et al. (2025) · Proceedings of the National Academy of Sciences

Dementia and Cognitive Impairment ResearchAdvanced MRI Techniques and Applications

Cited by 18

A Prescription for Wellness in Early PD: Just What the Doctor Ordered

McDaniels, B., Pontone, G. M., Keener, A. M., & Subramanian, I. (2023) · Journal of Geriatric Psychiatry and Neurology

Parkinson's Disease Mechanisms and TreatmentsCancer survivorship and care

Cited by 15